&UR; FOR TUESDAY AMs  &LR;    &UR; Financial stories in sight at this hour from The New York Times News Service for newspapers of TUESDAY, June 2.
&LR;    For information and repeats call the News Service at (212) 556-1927.
And be sure to look for other financial stories from our partners: Bloomberg News, The Boston Globe, Cox News Service, Hearst Newspapers, The Houston Chronicle, The Arizona Republic, Kansas City Star, Fort Worth Star-Telegram, Los Angeles Daily News, San Francisco Chronicle and Seattle Post-Intelligencer.
AHP-MONSANTO (Undated) _ American Home Products acquires Monsanto for about $34.4 billion in stock, creating one of the world's largest makers of pharmaceuticals, seeds and herbicides.
The purchase price represents almost no premium to Monsanto's market value.
Monsanto, which spun off its chemicals business last year to focus on genetically engineered crops and agricultural products, agreed three weeks ago to buy DeKalb Genetics and Delta and Pine Land for $4.1 billion.
The acquisition by American Home adds Monsanto's arthritis drugs, including at least one potential blockbuster, to American Home's Advil painkiller and Premarin hormone-replacement therapy.
American Home and SmithKline Beecham broke off merger talks in January.
With    AHC-BIOTECH (Undated) _ Looking at biotechnology, which is driving the deal.
